1-27382599-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001330448.1(CD164L2):c.157G>A(p.Ala53Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000093 in 1,613,184 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001330448.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD164L2 | NM_001330448.1 | c.157G>A | p.Ala53Thr | missense_variant | 2/6 | ENST00000374030.3 | NP_001317377.1 | |
CD164L2 | NM_207397.5 | c.157G>A | p.Ala53Thr | missense_variant | 2/5 | NP_997280.2 | ||
CD164L2 | XM_011541441.2 | c.157G>A | p.Ala53Thr | missense_variant | 2/6 | XP_011539743.1 | ||
CD164L2 | XR_241190.4 | n.251G>A | non_coding_transcript_exon_variant | 2/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD164L2 | ENST00000374030.3 | c.157G>A | p.Ala53Thr | missense_variant | 2/6 | 5 | NM_001330448.1 | ENSP00000363142.1 | ||
CD164L2 | ENST00000374027.7 | c.157G>A | p.Ala53Thr | missense_variant | 2/5 | 1 | ENSP00000363139.3 | |||
CD164L2 | ENST00000374025.4 | n.224G>A | non_coding_transcript_exon_variant | 2/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152144Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250874Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135680
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461040Hom.: 0 Cov.: 36 AF XY: 0.00000550 AC XY: 4AN XY: 726830
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152144Hom.: 0 Cov.: 31 AF XY: 0.0000673 AC XY: 5AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2024 | The c.157G>A (p.A53T) alteration is located in exon 2 (coding exon 2) of the CD164L2 gene. This alteration results from a G to A substitution at nucleotide position 157, causing the alanine (A) at amino acid position 53 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at